Avastin Improves Survival of Breast Cancer Patients, says UPMC Study
According to a University of Pittsburgh Cancer Institute (UPCI) study that will be presented on Dec. 11, 2009, patients who are being treated for a metastatic breast cancer for the second time may get better results if Avastin is added to their treatment.
Avastin inhibits the formation of new blood vessels that would supply tumors with oxygen and nutrients needed to grow, said the director of the Breast Cancer Center at Magee Womens Hospital of UPMC.
The study showed that Avastin added to standard chemotherapy improved survival.
Nearly 200,000 individuals will be diagnosed with breast cancer in 2010, and over 40,000 will die from breast cancer.